Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-19 10:05:05 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S0140-6736(25)01185-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673625011857
其他信息:
出版社: Elsevier BV
作者: Kirsten Dahl; Søren Toubro; Sohan Dey; Ruben Duque do Vale; Anne Flint; Agnes Gasiorek; Arne Heydorn; Ania M Jastreboff; Cassandra Key; Signe Beck Petersen; Andreas Vegge; Kasper Adelborg

